Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
 3 Months Ended
Feb. 29, 2012
Feb. 28, 2011
Cash Flows from Operating Activities:    
Net (loss) income $ (1,682,063) $ 233,419
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization expense 110,204 126,124
Loss on sale of property and equipment   1,214
Compensatory element of stock options 259,421 59,093
Provision for doubtful accounts 135,491 37,287
Equity in losses of affiliate 38,832 28,090
Loss on extinguishment of revenue sharing agreement 1,227,390  
Changes in assets and liabilities:    
Accounts receivable (142,967) (305,499)
Prepaid expenses and other current assets (24,747) (206,627)
Deposits and other assets 5,000 6,993
Accounts payable 402,304 276,391
Accrued expenses 93,264 136,254
Deferred consulting obligation (26,705) (24,902)
Deferred revenue (237,517) (130,079)
Net cash provided by operating activities 157,907 237,758
Cash flows from investing activities:    
Purchases of property and equipment (79,241) (229,602)
Proceeds from sale of marketable securities and other investments 1,002,000 20,000
Investments in patents (12,177) (19,934)
Net cash provided by (used in) investing activities 910,582 (229,536)
Cash flows from financing activities:    
Long-term liability-revenue sharing agreement (2,300,000)  
Treasury stock purchases (753,511)  
Net cash used in financing activities (3,053,511)  
(Decrease) increase in cash and cash equivalents (1,985,022) 8,222
Cash and cash equivalents - beginning of year 6,305,095 8,369,537
Cash and cash equivalents - end of period $ 4,320,073 $ 8,377,759